Organization
Strasbourg University Hospital
2 abstracts
Abstract
A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS)Org: UCB Pharma, Newcastle University, Strasbourg University Hospital, University of Palermo, Université Paris-Sud,
Abstract
ASSOCIATION OF CANCER AND ANTISYNTHETASE SYNDROME: A RETROSPECTIVE MULTICENTER STUDYOrg: Nancy University Hospital, Dijon University Hospital, University of Bourgogne-Franche Comté, Lorraine University, Paris Descartes University, EA 4360 Apemac, Nancy, Bourgogne-Franche Comté University,